文献速递消化道肿瘤与早癌

组蛋白去甲基化酶JMJD2D与β-catenin相互作用诱导转录并激活小鼠结直肠癌细胞增殖与肿瘤生长

Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
PubMed 文献 · Gastroenterology · 2018-11-23

研究显示结直肠癌组织中JMJD2D水平显著高于非肿瘤结肠组织,JMJD2D与β-catenin物理互作并在其靶基因启动子区去甲基化H3K9me3,激活转录,促进CRC细胞增殖、迁移、侵袭及小鼠肿瘤形成;JMJD2D敲除或抑制剂5-c-8HQ可减少小鼠结肠肿瘤。

要点

  • 人结直肠癌组织中JMJD2D水平显著高于对照非肿瘤组织,且与增殖细胞核抗原水平相关。
  • JMJD2D与β-catenin物理互作,在β-catenin靶基因启动子区去甲基化H3K9me3以激活转录。
  • JMJD2D敲除或抑制剂5-c-8HQ可减少小鼠结肠炎相关结直肠肿瘤及Apcmin/+小鼠肠道结肠肿瘤。

核心结论

  • 人结直肠肿瘤中组蛋白去甲基化酶JMJD2D水平较非肿瘤结肠组织升高。
  • JMJD2D与β-catenin互作激活其靶基因转录,促进CRC细胞增殖、迁移、侵袭及小鼠结直肠肿瘤形成。

研究设计与样本

  • 获取中国接受手术患者的结直肠肿瘤标本及周围非肿瘤结肠组织(对照),用免疫组化或免疫印迹检测JMJD2D水平。
  • 用短发夹RNA敲低CRC细胞(CT26、HCT116和SW480)中JMJD2D,进行活力、流式细胞术、集落形成及Transwell迁移和侵袭实验。
  • 将细胞作为肿瘤异种移植瘤在裸鼠中生长或注入小鼠尾静脉或脾脏并测量转移。
  • 进行启动子活性、免疫共沉淀和染色质免疫沉淀实验。
  • 用Apcmin/+与JMJD2D敲除小鼠杂交,分析子代(Apcmin/+Jmjd2d+/+和Apcmin/+Jmjd2d-/-)结直肠肿瘤形成。

主要发现

  • 人结直肠肿瘤中JMJD2D水平显著高于对照组织,且与增殖细胞核抗原水平相关。
  • JMJD2D敲低减少CRC细胞增殖、迁移和侵袭,以及小鼠异种移植瘤生长和转移形成。
  • JMJD2D为CRC细胞系中β-catenin表达所必需;JMJD2D异位表达增加β-catenin调控基因(MYC、CCND1、MMP2和MMP9)的启动子活性。
  • JMJD2D与β-catenin物理互作,JMJD2D在β-catenin靶基因启动子区去甲基化H3K9me3。
  • JMJD2D敲除小鼠结肠炎相关结直肠肿瘤少于对照小鼠,其肿瘤组织β-catenin、MYC、cyclin D1和增殖细胞核抗原水平低于对照小鼠肿瘤。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Wnt signaling contributes to the development of colorectal cancer (CRC). We studied interactions between lysine demethylase 4D (KDM4D or JMJD2D) and β-catenin, a mediator of Wnt signaling, in CRC cell lines and the effects on tumor formation in mice. METHODS: We obtained colorectal tumor specimens and surrounding nontumor colon tissues (controls) from patients undergoing surgery in China; levels of JMJD2D were measured by immunohistochemical or immunoblot analysis. JMJD2D expression was knocked down in CRC (CT26, HCT116, and SW480 cells) using small hairpin RNAs, and cells were analyzed with viability, flow cytometry, colony formation, and transwell migration and invasion assays. Cells were also grown as tumor xenografts in nude mice or injected into tail veins or spleens of mice, and metastases were measured. We performed promoter activity, co-immunoprecipitation, and chromatin immunoprecipitation assays. We also performed studies with Apcmin/+ and JMJD2D-knockout mice; these mice were crossed, and colorectal tumor formation in offspring (Apcmin/+Jmjd2d+/+ and Apcmin/+Jmjd2d-/-) was analyzed. JMJD2D-knockout and wild-type (control) mice were given azoxymethane followed by dextran sodium sulfate to induce colitis-associated CRC; some mice were given the JMJD2D inhibitor 5-chloro-8-hydroxyquinoline (5-c-8HQ) or vehicle to examine the effects of 5-c-8HQ on intestinal tumor formation. RESULTS: Levels of JMJD2D were significantly higher in human colorectal tumors than in control tissues and correlated with levels of proliferating cell nuclear antigen. JMJD2D knockdown reduced CRC cell proliferation, migration, and invasion, as well as growth of xenograft tumors and formation of metastases in mice. JMJD2D was required for expression of β-catenin in CRC cell lines; ectopic expression of JMJD2D increased the promoter activities of genes regulated by β-catenin (MYC, CCND1, MMP2, and MMP9). We found that JMJD2D and β-catenin interacted physically and that JMJD2D demethylated H3K9me3 at promoters of β-catenin target genes. JMJD2D-knockout mice developed fewer colitis-associated colorectal tumors than control mice, and their tumor tissues had lower levels of β-catenin, MYC, cyclin D1, and proliferating cell nuclear antigen than tumors from control mice. Apcmin/+Jmjd2d-/- mice developed fewer and smaller colon tumors than Apcmin/+ mice. Mice given 5-c-8HQ developed smaller and fewer colitis-associated tumors, with lower levels of cell proliferation, than mice given vehicle. Apcmin/+ mice given 5-c-8HQ also developed fewer tumors in intestines and colons than mice given vehicle. CONCLUSIONS: Levels of the histone demethylase JMJD2D are increased in human colorectal tumors compared with nontumor colon tissues. JMJD2D interacts with β-catenin to activate transcription of its target genes and promote CRC cell proliferation, migration, and invasion, as well as formation of colorectal tumors in mice.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Peng K, Kou L, Yu L, et al. Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice. Gastroenterology. 2018. PMID: 30472235. doi:10.1053/j.gastro.2018.11.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。